Daniel J. Weisdorf, MD [clinicaltrials_resource:edfe015e91a76f89097fbe9e45303fc5]
Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00005985]Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00005987]Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00005998]
overall official [clinicaltrials_vocabulary:overall-official]
Daniel J. Weisdorf, MD [clinicaltrials_resource:edfe015e91a76f89097fbe9e45303fc5]
Bio2RDF identifier
edfe015e91a76f89097fbe9e45303fc5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:edfe015e91a76f89097fbe9e45303fc5
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Daniel J. Weisdorf, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:edfe015e91a76f89097fbe9e45303fc5
title
Daniel J. Weisdorf, MD
@en
type
label
Daniel J. Weisdorf, MD [clinicaltrials_resource:edfe015e91a76f89097fbe9e45303fc5]
@en